The Paris Technology and Life Sciences team advised Vidi Capital on its acquisition of the Centre d’Imagerie du Languedoc (CIL11), a key player in medical imaging.
With the acquisition of the CIL11 group, Vidi Capital positions itself as a leading actor in diagnostic and therapeutic medical imaging in France.
Founded in 2022 by radiologists from the Vidi network, the leading private imaging network in France with nearly 1,250 members, Vidi Capital offers an innovative model to develop independent medical imaging. Its mission is to ensure excellence in care and address the sector’s key challenges, in a context of major restructuring.
The Centre d’Imagerie Médicale du Languedoc is a leading actor in medical imaging in the Aude department in southern France, offering advanced diagnostic solutions and personalized support for each patient.
The Goodwin team included William Robert and William Ducrocq Ferre on corporate matters, Charles-Henri de Gouvion Saint-Cyr and Paul Fournière on tax matters, as well as Adrien Paturaud, Alexander Hahn, Elisa Revel and Jad Bezzari on financing aspects.